Figure 1From: Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesityMean change of body weight, waist circumference and BMI in the two groups. *p<0.001 for the between-treatment difference.Back to article page